800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

A Study of Mosliciguat in PH-ILD (PHocus)

view all Clinical Trials

Overview

This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Clinical Trial Information

Protocol

TIRB#: 32203

Phase

2

Condition(s)

Interstitial Lung Disease (ILD), Pulmonary Hypertension (PH), Pulmonary Vascular Disease

Investigator

Parth Rali, MD

Coordinator

Kim Selwood

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease